Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.72 and traded as high as $1.03. Mesoblast shares last traded at $1.03, with a volume of 100 shares traded.
Mesoblast Trading Up 15.6 %
The stock has a fifty day moving average price of $0.72 and a two-hundred day moving average price of $0.72.
Mesoblast Company Profile
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Featured Stories
- Five stocks we like better than Mesoblast
- Conference Calls and Individual Investors
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- Most active stocks: Dollar volume vs share volume
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- There Are Different Types of Stock To Invest In
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
